Barme M, Tsiang H
Institut Pasteur, Paris.
Bull Acad Natl Med. 1995 May;179(5):1023-32.
Since the first immunization of man against rabies in 1885 by Louis Pasteur, antirabies vaccine has been continuously improved. Treatment failures, clinical infections by the fixed virus, neuroparalytic accidents in connection with myelin were progressively eliminated. Vaccines can be standardized and accurately controlled. After the original spinal cord, adult or newborn animals brains, embryonated eggs, primary tissue cultures, diploid and permanent cell lines have been used for the vaccine production. Today, safe and potent vaccines are available. New products might be developed from the technology of genetic recombinants.
自1885年路易·巴斯德首次对人进行狂犬病免疫接种以来,抗狂犬病疫苗一直在不断改进。治疗失败、固定病毒引起的临床感染以及与髓磷脂相关的神经麻痹事故逐渐被消除。疫苗可以标准化并得到精确控制。在最初使用脊髓、成年或新生动物的大脑、带胚鸡蛋、原代组织培养物、二倍体细胞系和永久细胞系来生产疫苗之后,如今已有安全有效的疫苗可供使用。利用基因重组技术可能会研发出新产品。